Loading
SOX9 (Transcription factor SOX-9) is a gene whose normal job is to hold cell growth in check. The public catalogues list it as a tumour suppressor, and it is called a cancer driver by mutation analysis of patient cohorts. Tied to Colorectal cancer.
Transcription factor that plays a key role in chondrocytes differentiation and skeletal development. Specifically binds the 5'-ACAAAG-3' DNA motif present in enhancers and super-enhancers and promotes expression of genes important for chondrogenesis, including cartilage matrix protein-coding genes COL2A1, COL4A2, COL9A1, COL11A2 and ACAN, SOX5 and SOX6. Also binds to some promoter regions.
Open Targets scores its association with cancer at 0.68 (direct and indirect evidence; datatypes literature 1.00, animal model 0.51, genetic association 0.66, somatic mutation 0.73). IntOGen calls it a driver in 5 cohorts (0 activating, 5 loss-of-function), covering Colon Adenocarcinoma, Colorectal Adenocarcinoma.
In plain words · SOX9 (Transcription factor SOX-9) is a gene whose normal job is to hold cell growth in check. The public catalogues list it as a tumour suppressor, and it is called a cancer driver by mutation analysis of patient cohorts. Tied to Colorectal cancer.
SOX9 (Transcription factor SOX-9) is a gene whose normal job is to hold cell growth in check. The public catalogues list it as a tumour suppressor, and it is called a cancer driver by mutation analysis of patient cohorts. Tied to Colorectal cancer.
Transcription factor that plays a key role in chondrocytes differentiation and skeletal development.
No product in this corpus aims at SOX9 yet. Because the protein is lost rather than overactive, drugs either restore its function or exploit the weakness its loss leaves (synthetic lethality).
First described 1994. Earliest sequence paper UniProt cites for the protein: Foster J.W. et al, Nature, 1994, "Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene". Source.
Sources: HGNC HGNC:11204 (approved symbol, name, aliases, locus and cross-references (hgnc_complete_set.txt)); UniProt P48436 (protein name, function text, keywords and locations (REST API)); Open Targets ENSG00000125398 (association with cancer (MONDO_0004992) 0.68; per-cancer scores at or above 0.5: colorectal cancer 0.64 (GraphQL API, CC0)); IntOGen SOX9 (driver in 5 cohorts (Act 0, LoF 5); Compendium_Cancer_Genes.tsv release 20240920, CC0 1.0)
Transcription factor that plays a key role in chondrocytes differentiation and skeletal development. Specifically binds the 5'-ACAAAG-3' DNA motif present in enhancers and super-enhancers and promotes expression of genes important for chondrogenesis, including cartilage matrix protein-coding genes COL2A1, COL4A2, COL9A1, COL11A2 and ACAN, SOX5 and SOX6. Also binds to some promoter regions. Plays a central role in successive steps of chondrocyte differentiation. Absolutely required for precartilaginous condensation, the first step in chondrogenesis during which skeletal progenitors differentiate into prechondrocytes. Together with SOX5 and SOX6, required for overt chondrogenesis when condensed prechondrocytes differentiate into early stage chondrocytes, the second step in chondrogenesis. Location: Nucleus (UniProt). Locus 17q24.3 (HGNC).
| Cancer | Prevalence | Measure | Note | Source |
|---|---|---|---|---|
| Colorectal cancer | 10-12% | Inactivating mutation | cBioPortal: 869 of 7,237, 12.0%, in crc_msk_2026; 64 of 534, 12.0%, in coadread_tcga_pan_can_atlas_2018; 62 of 619, 10.0%, in coadread_dfci_2016; 154 of 1,516, 10.2%, in crc_eo_2020; 107 of 1,134, 9.4%, in crc_msk_2017. Named as a new significantly mutated gene by the TCGA analysis (Cancer Genome Atlas Network 2012). | cBioPortal (TCGA) |
Approximate, population-level figures; the measure column says what was counted. Ranges show the midpoint as a bar.
Query for this target: (TITLE:"SOX9" OR ABSTRACT:"SOX9" OR TITLE:"SRY-box transcription factor 9" OR ABSTRACT:"SRY-box transcription factor 9" OR TITLE:"Transcription factor SOX-9" OR ABSTRACT:"Transcription factor SOX-9" OR TITLE:"SRA1" OR ABSTRACT:"SRA1" OR TITLE:"CMD1" OR ABSTRACT:"CMD1" OR TITLE:"CMPD1" OR ABSTRACT:"CMPD1") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about SOX9, not a curated reading list.
Shares Comprehensive molecular characterization of human colon and rectal cancer, IntOGen, Open Targets Platform, Colorectal cancer.
Shares Comprehensive molecular characterization of human colon and rectal cancer, IntOGen, Open Targets Platform, Colorectal cancer.
Shares Comprehensive molecular characterization of human colon and rectal cancer, IntOGen, Open Targets Platform, Colorectal cancer.
Shares Comprehensive molecular characterization of human colon and rectal cancer, IntOGen, Open Targets Platform, Colorectal cancer.
Shares Comprehensive molecular characterization of human colon and rectal cancer, IntOGen, Open Targets Platform, Colorectal cancer.
Shares Comprehensive molecular characterization of human colon and rectal cancer, Colorectal cancer.
Shares Comprehensive molecular characterization of human colon and rectal cancer, Colorectal cancer.
Shares Comprehensive molecular characterization of human colon and rectal cancer, Colorectal cancer.